---
title: 'Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an
  extended case study'
date: '2024-12-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39673062/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241214171558&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: This report describes for the first time the phenotypic
  recovery of innate Fcγ-receptor-expressing cells in an SSc patient treated with
  CAR-T cells. Decreasing autoantibody levels associated with a reduced ability to
  form functional immune complexes, the latter appearing to contribute to pathology
  in SSc via activation of Fcγ receptor IIIA + cells such as NK ...'
disable_comments: true
---
CONCLUSION: This report describes for the first time the phenotypic recovery of innate Fcγ-receptor-expressing cells in an SSc patient treated with CAR-T cells. Decreasing autoantibody levels associated with a reduced ability to form functional immune complexes, the latter appearing to contribute to pathology in SSc via activation of Fcγ receptor IIIA + cells such as NK ...